|Bid||253.00 x 800|
|Ask||253.15 x 800|
|Day's Range||251.60 - 253.90|
|52 Week Range||191.53 - 253.90|
|PE Ratio (TTM)||103.80|
|Earnings Date||Oct 31, 2018 - Nov 5, 2018|
|Forward Dividend & Yield||3.00 (1.19%)|
|1y Target Est||267.13|
In 2012, Baxter International (BAX) adopted a $2 billion share buyback program. In November 2016 and February 2018, the company increased the program by $1.5 billion each.
Henderson, 53, is the non-executive chairman of the board of Qualcomm, Inc. and serves on the board of directors at FibroGen, Inc. and Halozyme Therapeutics, Inc. as well as serving as an advisory director to Berkshire Partners LLC. Prior to these roles, he served for nearly 10 years as chief financial officer of Cardinal Health, a $137 billion global health care services and products company, and also oversaw the company's China and Canada operations. Prior to Cardinal Health, Henderson spent seven years at Eli Lilly & Co. where he was vice president and corporate controller, as well as president and general manager of its Canada operations.
Haemonetics’s Fiscal Q1 Earnings Surpass Analyst Estimates A look at Haemonetics’s Q1 2019 estimates Haemonetics (HAE), a leading healthcare company in blood management solutions, released its fiscal Q1 2019 earnings on August 7.
In its fiscal third-quarter conference call, Hologic (HOLX) narrowed the projected range of its fiscal 2018 EPS from $2.22–$2.27 to $2.24–$2.26. Considering the midpoint of the updated EPS guidance range, the company expects YoY (year-over-year) EPS growth of ~10.8% for fiscal 2018.
During its fiscal third quarter conference call, Hologic (HOLX) raised its fiscal 2018 non-GAAP revenue guidance from $3.18 billion–$3.21 billion to ~$3.21 billion–$3.22 billion. So, its YoY (year-over-year) reported revenue growth rate for fiscal 2018 is expected to be 4.8%–5.3%, higher than the previously projected range of 4.0%–4.9%.
In the fiscal third quarter, Hologic reported non-GAAP EPS of ~$0.58, which was a YoY rise of 16.0%. Hologic surpassed its revenue and EPS guidance for the fiscal third quarter. Hologic’s Diagnostics business posted a recovery compared to the fiscal second quarter, and its Surgical business has posted gradual improvement since the fiscal first quarter.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, growth of ETFs holding BDX is favorable, with net inflows of $10.57 billion.
Becton Dickinson (BDX) delivered earnings and revenue surprises of 2.11% and 0.97%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the Franklin Lakes, New Jersey-based company said it had net income of $2.03. Earnings, adjusted for non-recurring costs and restructuring costs, came to $2.91 per share. The results ...
- As reported, revenues of $4.278 billion increased 41.0 percent. - On a comparable, currency-neutral basis, revenues increased 5.5 percent. - As reported, diluted earnings per share of $2.03 increased ...
Becton Dickinson (NYSE: BDX ) will be releasing its next round of earnings. For all of the relevant information, here is your guide for Thursday's Q3 earnings announcement. Earnings and Revenue Becton ...
During Abbott Laboratories’ (ABT) second-quarter earnings release on July 18, the company increased its fiscal 2018 guidance. This move was triggered by the company’s strong performance in the quarter. ABT stock rose ~3.1% on the day of its earnings announcement.
FRANKLIN LAKES, N.J. , Aug. 1, 2018 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today appointed Simon Campion as executive vice president ...
Fortunately, Simply Safe Dividends identified the 10 best dividend growth stocks that investors can rely on for secure, fast-growing income. Let’s take a look at 10 of the safest dividend growth stocks in the market.
BD® AbSeq Assay Enables Deeper Understanding of Role Individual Cells Play in the Immune System FRANKLIN LAKES, N.J. , July 26, 2018 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading ...